UK Stocks-Factors to watch on Dec. 23

Dec 23 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Thursday, with futures FFIc1 up 0.43%.

* ASTRAZENECA: AstraZeneca AZN.L said its COVID-19 vaccine was effective against the Omicron coronavirus variant following a third dose in a study, with neutralising levels similar to those against the Delta variant after a regular two-dose course.

* FLUTTER ENTERTAINMENT: Betfair and Poker Stars owner Flutter Entertainment FLTRF.L said it would buy Italian online gaming operator Sisal for 1.62 billion pounds ($2.16 billion), as it looks to expand its footprint in Europe.

* BALFOUR BEATTY: The U.S. Justice Department said it resolved probes into Balfour Beatty Communities, one of the U.S. military's largest private landlords, after it pleaded guilty on Wednesday to one count of major fraud and agreed to pay over $65 million in fines and restitution.

* CAR PLANTS: British car manufacturers had their slowest November in 37 years as the sector struggled to cope with the impact of the pandemic on global supply chains, industry data showed.

* UK BUSINESS: British businesses have reported their weakest growth since the country was under lockdown earlier this year and they expect a further slowdown in early 2022, the Confederation of British Industry said.

* GOLD: Gold prices edged up in thin year-end trading, as the safe-haven dollar weakened following encouraging studies on the Omicron COVID-19 variant and rising optimism about the global economic outlook.

* METAL: Copper edged higher, underpinned by a weak U.S. dollar, easing concerns about the Omicron coronavirus variant and upbeat U.S. economic data.

* OIL: Oil prices edged up for a third consecutive session over positive developments around COVID-19, even as China imposed new travel curbs and Australia reinstated restrictions to combat surging cases.

* UK's FTSE 100 ended higher on Wednesday as gains in industrial and financial stocks helped counter concerns over the impact of the Omicron coronavirus variant on economic recovery and weaker-than-expected quarterly growth data.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting By Amna Karimi in Bengaluru; Editing by Vinay Dwivedi

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.